T Rowe Price Health Sciences F's ticker is and the CUSIP is 741480107. A total of 4 filers reported holding T Rowe Price Health Sciences F in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $125,935 | -4.4% | 1,467 | 0.0% | 0.04% | -2.7% |
| Q2 2023 | $131,731 | +2.3% | 1,467 | 0.0% | 0.04% | -2.6% |
| Q1 2023 | $128,752 | -1.4% | 1,467 | 0.0% | 0.04% | -88.2% |
| Q4 2022 | $130,645 | -99.9% | 1,467 | 0.0% | 0.32% | +9.2% |
| Q3 2022 | $123,221,000 | -13.1% | 1,467 | 0.0% | 0.30% | -8.1% |
| Q2 2022 | $141,752,000 | 0.0% | 1,467 | 0.0% | 0.32% | +3.2% |
| Q1 2022 | $141,752,000 | -11.7% | 1,467 | 0.0% | 0.31% | -15.0% |
| Q4 2021 | $160,592,000 | 0.0% | 1,467 | 0.0% | 0.37% | -1.1% |
| Q3 2021 | $160,592,000 | +1.1% | 1,467 | 0.0% | 0.37% | +0.5% |
| Q2 2021 | $158,831,000 | +9.8% | 1,467 | 0.0% | 0.37% | -3.7% |
| Q1 2021 | $144,628,000 | -0.3% | 1,467 | 0.0% | 0.38% | -4.0% |
| Q4 2020 | $145,039,000 | +6.3% | 1,467 | 0.0% | 0.40% | +541.9% |
| Q3 2020 | $136,485,000 | +6.8% | 1,467 | 0.0% | 0.06% | -17.3% |
| Q2 2020 | $127,740,000 | +23.5% | 1,467 | 0.0% | 0.08% | +5.6% |
| Q1 2020 | $103,442,000 | -9.7% | 1,467 | +0.1% | 0.07% | +91.9% |
| Q3 2018 | $114,505,000 | -1.8% | 1,466 | -0.1% | 0.04% | -9.8% |
| Q2 2018 | $116,560,000 | – | 1,467 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Westside Investment Management, Inc. | 1,467 | $145,039,000 | 0.40% |
| HOWARD CAPITAL MANAGEMENT | 2,985 | $295,000 | 0.03% |
| DIVIDEND ASSETS CAPITAL, LLC | 420 | $42,000 | 0.01% |
| GOFEN & GLOSSBERG LLC /IL/ | 2,417 | $239,000 | 0.01% |